LENZ Therapeutics Inc.
LENZ | NASDAQ
$4.08
+$0.01 (+0.25%)
At close: Sep 21, 2026, 4:00 PM ET
$4.08
$0 (0.00%)
Pre-market:
Sep 22, 2026, 8:29 AM ET
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -126M | -109M | -82.13M | -58.88M | -52.4M | -47.74M | -49.77M | -60.81M | -69.47M | -73.95M | -69.97M | -55.71M | -61.51M | -73.44M | -86.92M | -96.42M | -86.33M | -77.2M | -70.76M | -115.37M | -100.77M | -84.56M |
Depreciation & Amortization | -2.96M | -3.05M | -3.12M | 205K | 90K | 89K | 58K | 37K | 31K | 17K | 15K | 14K | 2.18M | 4.24M | 6.13M | 6.12M | 4.51M | 2.55M | 746K | 867K | 311K | 212K |
Stock-Based Compensation | 11.62M | 9.99M | 12.55M | 10.5M | 9.22M | 7.97M | 6.37M | 5.25M | 3.56M | 1.96M | 1.15M | 1.01M | 519K | 519K | 377K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Working Capital | -2.78M | 6.39M | 6.67M | 5.7M | 2.53M | -3.27M | -8.81M | -8.93M | -5.62M | 1.28M | 9.3M | 5.39M | -1.1M | -6.4M | -7.95M | -7.18M | -5.86M | -5.69M | -4.32M | -3.21M | -1.79M | 30K |
Other Non-Cash Items | 6.51M | 5.75M | 279K | -4.13M | -4.71M | -4.78M | -2.95M | -2.33M | -1.39M | 7.27M | 6.51M | 7.29M | 10.36M | 6.78M | 10.46M | 14.35M | 14.07M | 11.98M | 19.66M | 73.86M | 71.49M | 69.48M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -3.07M | 9.6M | 3.25M | 7.08M | 578K | -7.05M | -13.09M | -13.44M | -6.52M | 1.46M | 10.18M | 8.79M | 727K | -2.67M | -3.06M | -5.2M | -6.6M | -3.37M | -2.5M | -1.89M | 1.86M | 586K |
Operating Cash Flow | -113.91M | -86.7M | -69.17M | -45.22M | -47.22M | -51.5M | -59.39M | -71.28M | -73.79M | -63.24M | -52.1M | -38.6M | -47.73M | -64.57M | -73.01M | -81.14M | -74.34M | -66.03M | -52.85M | -42.53M | -27.12M | -14.28M |
Capital Expenditures | -511K | -735K | -827K | -938K | -685K | -578K | -468K | -319K | -133K | 353K | 347K | 344K | -571K | -2.31M | -5.58M | -6.55M | -9.28M | -8.65M | -5.74M | -5.37M | -1.73M | -1.35M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -212.85M | -263.77M | -280.8M | -194.31M | -222.04M | -163.75M | -130.65M | -89.87M | -25.24M | -23.96M | -23.96M | -18.14M | -84.31M | -172.42M | -339.81M | -339.81M | -254.23M | -167.39M | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 190.13M | 203.11M | 205.96M | 197.52M | 167.11M | 121.99M | 87.9M | 74M | 53.5M | -31.18M | -49.18M | -70.18M | 18.33M | 90M | 90M | 90M | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | -111.26M | -111.26M | -111.26M | -111.26M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -23.23M | -61.4M | -75.67M | 2.28M | -55.61M | -153.59M | -154.48M | -127.44M | -83.13M | -54.78M | -72.79M | -87.97M | -66.56M | -84.73M | -255.39M | -256.37M | -263.5M | -176.05M | -5.74M | -5.37M | -1.74M | -1.35M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 8K | 8K | 8K | -71K | -79K | -79K | -79K | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | 421K | 421K | 559K | 546K | 1.55M | 119.43M | 117.38M | 116.83M | 115.4M | -2.28M | -350K | 218K | 218K | 15K | 306K | 306K | 306K | 306K | n/a | n/a | n/a |
Financial Cash Flow | 123.62M | 149.72M | 149.75M | 27.18M | 56.4M | 27.78M | 199M | 197.04M | 166.65M | 251.98M | 163.89M | 186.05M | 186.56M | 103.79M | 20.61M | 666K | 32.62M | 251.7M | 417.47M | 432.28M | 400.39M | 195.89M |
Net Cash Flow | -13.51M | 1.62M | 4.91M | -15.76M | -46.43M | -177.32M | -14.87M | -1.69M | 9.73M | 184.75M | 89.79M | 110.29M | 123.08M | -45.52M | -307.8M | -338.56M | -306.94M | 7.91M | 357.16M | 394.95M | 382.11M | 177.16M |
Free Cash Flow | -114.42M | -87.44M | -70M | -46.16M | -47.9M | -52.08M | -59.86M | -71.6M | -73.92M | -62.89M | -51.76M | -38.25M | -48.3M | -66.88M | -78.59M | -87.7M | -83.62M | -74.69M | -58.59M | -47.9M | -28.85M | -15.64M |
Adj. Free Cash Flow | -126.04M | -97.43M | -82.54M | -56.66M | -57.12M | -60.05M | -66.22M | -76.86M | -77.48M | -64.85M | -52.91M | -39.27M | -48.82M | -67.4M | -78.97M | -87.7M | -83.62M | -74.69M | -58.59M | -47.9M | -28.85M | -15.64M |
Maintenance CapEx | -34K | -18K | -110K | -259K | -445K | -578K | -468K | -319K | -133K | 353K | 347K | 344K | -571K | -2.31M | -5.58M | -5.57M | -5.21M | -3.93M | -746K | -867K | -312K | n/a |
Growth CapEx | -477K | -717K | -717K | -679K | -240K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -981K | -4.06M | -4.72M | -4.99M | -4.5M | -1.8M | n/a |
Owner Earnings | -113.94M | -86.72M | -69.28M | -45.48M | -47.66M | -52.08M | -59.86M | -71.6M | -73.92M | -62.89M | -51.76M | -38.25M | -48.3M | -66.88M | -78.59M | -86.72M | -79.56M | -69.96M | -53.6M | -43.4M | -28.38M | n/a |
Add to Watchlist
Select watchlists to add or remove LENZ